nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—CYP2B6—Thiotepa—sarcoma	0.409	0.539	CbGbCtD
Prasugrel—CYP3A4—Thiotepa—sarcoma	0.126	0.166	CbGbCtD
Prasugrel—CYP2B6—Doxorubicin—sarcoma	0.0756	0.0997	CbGbCtD
Prasugrel—CYP3A4—Mitoxantrone—sarcoma	0.054	0.0712	CbGbCtD
Prasugrel—CYP3A4—Vincristine—sarcoma	0.0372	0.049	CbGbCtD
Prasugrel—CYP3A4—Etoposide—sarcoma	0.0341	0.0449	CbGbCtD
Prasugrel—CYP3A4—Doxorubicin—sarcoma	0.0232	0.0306	CbGbCtD
Prasugrel—Thrombocytopenic purpura—Thiotepa—sarcoma	0.00639	0.0331	CcSEcCtD
Prasugrel—Haemorrhage intracranial—Mitoxantrone—sarcoma	0.00631	0.0327	CcSEcCtD
Prasugrel—CES2—mammary gland—sarcoma	0.00447	0.0923	CbGeAlD
Prasugrel—P2RY12—hematopoietic system—sarcoma	0.00427	0.0881	CbGeAlD
Prasugrel—Neoplasm malignant—Thiotepa—sarcoma	0.00351	0.0182	CcSEcCtD
Prasugrel—CES2—myometrium—sarcoma	0.00317	0.0655	CbGeAlD
Prasugrel—Haematochezia—Epirubicin—sarcoma	0.003	0.0155	CcSEcCtD
Prasugrel—Contusion—Mitoxantrone—sarcoma	0.00297	0.0154	CcSEcCtD
Prasugrel—Pericardial effusion—Epirubicin—sarcoma	0.00294	0.0152	CcSEcCtD
Prasugrel—CES2—seminal vesicle—sarcoma	0.00286	0.0591	CbGeAlD
Prasugrel—Haematochezia—Doxorubicin—sarcoma	0.00277	0.0144	CcSEcCtD
Prasugrel—Pericardial effusion—Doxorubicin—sarcoma	0.00272	0.0141	CcSEcCtD
Prasugrel—CES2—hematopoietic system—sarcoma	0.00272	0.0562	CbGeAlD
Prasugrel—ALB—mammary gland—sarcoma	0.00256	0.0528	CbGeAlD
Prasugrel—CES2—smooth muscle tissue—sarcoma	0.0024	0.0495	CbGeAlD
Prasugrel—CES2—skin of body—sarcoma	0.00237	0.0489	CbGeAlD
Prasugrel—Ecchymosis—Mitoxantrone—sarcoma	0.00234	0.0121	CcSEcCtD
Prasugrel—Gingival bleeding—Epirubicin—sarcoma	0.00213	0.011	CcSEcCtD
Prasugrel—CES2—cardiac atrium—sarcoma	0.00207	0.0427	CbGeAlD
Prasugrel—CES2—uterus—sarcoma	0.00206	0.0425	CbGeAlD
Prasugrel—Gingival bleeding—Doxorubicin—sarcoma	0.00197	0.0102	CcSEcCtD
Prasugrel—Pain in extremity—Vincristine—sarcoma	0.00193	0.00999	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Mitoxantrone—sarcoma	0.00188	0.00973	CcSEcCtD
Prasugrel—CES2—tendon—sarcoma	0.0018	0.0372	CbGeAlD
Prasugrel—CES2—bone marrow—sarcoma	0.00174	0.036	CbGeAlD
Prasugrel—Hyperlipidaemia—Epirubicin—sarcoma	0.00167	0.00867	CcSEcCtD
Prasugrel—Haemoptysis—Epirubicin—sarcoma	0.00163	0.00845	CcSEcCtD
Prasugrel—Haematuria—Thiotepa—sarcoma	0.0016	0.00828	CcSEcCtD
Prasugrel—CYP2C9—mammary gland—sarcoma	0.0016	0.033	CbGeAlD
Prasugrel—Epistaxis—Thiotepa—sarcoma	0.00158	0.00819	CcSEcCtD
Prasugrel—Hyperlipidaemia—Doxorubicin—sarcoma	0.00155	0.00803	CcSEcCtD
Prasugrel—Haemoglobin—Thiotepa—sarcoma	0.00151	0.00784	CcSEcCtD
Prasugrel—Haemoptysis—Doxorubicin—sarcoma	0.00151	0.00782	CcSEcCtD
Prasugrel—Haemorrhage—Thiotepa—sarcoma	0.00151	0.0078	CcSEcCtD
Prasugrel—CES2—testis—sarcoma	0.00149	0.0308	CbGeAlD
Prasugrel—Urinary tract disorder—Thiotepa—sarcoma	0.00149	0.0077	CcSEcCtD
Prasugrel—Urethral disorder—Thiotepa—sarcoma	0.00148	0.00764	CcSEcCtD
Prasugrel—Neoplasm malignant—Epirubicin—sarcoma	0.00141	0.00732	CcSEcCtD
Prasugrel—CES2—liver—sarcoma	0.00141	0.0291	CbGeAlD
Prasugrel—Eye disorder—Thiotepa—sarcoma	0.00141	0.00729	CcSEcCtD
Prasugrel—Haematuria—Mitoxantrone—sarcoma	0.00138	0.00715	CcSEcCtD
Prasugrel—Angiopathy—Thiotepa—sarcoma	0.00137	0.00707	CcSEcCtD
Prasugrel—Immune system disorder—Thiotepa—sarcoma	0.00136	0.00704	CcSEcCtD
Prasugrel—Mediastinal disorder—Thiotepa—sarcoma	0.00136	0.00703	CcSEcCtD
Prasugrel—Rectal haemorrhage—Epirubicin—sarcoma	0.00134	0.00692	CcSEcCtD
Prasugrel—Bradycardia—Mitoxantrone—sarcoma	0.00132	0.00685	CcSEcCtD
Prasugrel—Urinary tract disorder—Vincristine—sarcoma	0.00132	0.00683	CcSEcCtD
Prasugrel—Urethral disorder—Vincristine—sarcoma	0.00131	0.00678	CcSEcCtD
Prasugrel—Neoplasm malignant—Doxorubicin—sarcoma	0.00131	0.00677	CcSEcCtD
Prasugrel—Haemoglobin—Mitoxantrone—sarcoma	0.00131	0.00677	CcSEcCtD
Prasugrel—Haemorrhage—Mitoxantrone—sarcoma	0.0013	0.00673	CcSEcCtD
Prasugrel—Back pain—Thiotepa—sarcoma	0.00127	0.00657	CcSEcCtD
Prasugrel—CYP2C19—hematopoietic system—sarcoma	0.00125	0.0259	CbGeAlD
Prasugrel—Rectal haemorrhage—Doxorubicin—sarcoma	0.00124	0.0064	CcSEcCtD
Prasugrel—Anaemia—Thiotepa—sarcoma	0.00121	0.00627	CcSEcCtD
Prasugrel—Angiopathy—Vincristine—sarcoma	0.00121	0.00627	CcSEcCtD
Prasugrel—Mediastinal disorder—Vincristine—sarcoma	0.0012	0.00623	CcSEcCtD
Prasugrel—Anaemia—Dactinomycin—sarcoma	0.0012	0.00623	CcSEcCtD
Prasugrel—Leukopenia—Thiotepa—sarcoma	0.00117	0.00608	CcSEcCtD
Prasugrel—Leukopenia—Dactinomycin—sarcoma	0.00116	0.00603	CcSEcCtD
Prasugrel—Cough—Thiotepa—sarcoma	0.00114	0.00592	CcSEcCtD
Prasugrel—Hypertension—Thiotepa—sarcoma	0.00113	0.00586	CcSEcCtD
Prasugrel—Back pain—Vincristine—sarcoma	0.00112	0.00582	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00111	0.00574	CcSEcCtD
Prasugrel—Back pain—Mitoxantrone—sarcoma	0.00109	0.00567	CcSEcCtD
Prasugrel—Neoplasm—Epirubicin—sarcoma	0.00109	0.00565	CcSEcCtD
Prasugrel—Ecchymosis—Epirubicin—sarcoma	0.00109	0.00565	CcSEcCtD
Prasugrel—CES2—lymph node—sarcoma	0.00108	0.0223	CbGeAlD
Prasugrel—Anaemia—Vincristine—sarcoma	0.00107	0.00556	CcSEcCtD
Prasugrel—Urinary tract disorder—Etoposide—sarcoma	0.00107	0.00553	CcSEcCtD
Prasugrel—Urethral disorder—Etoposide—sarcoma	0.00106	0.00549	CcSEcCtD
Prasugrel—Thrombocytopenia—Thiotepa—sarcoma	0.00105	0.00542	CcSEcCtD
Prasugrel—Anaemia—Mitoxantrone—sarcoma	0.00105	0.00542	CcSEcCtD
Prasugrel—Leukopenia—Vincristine—sarcoma	0.00104	0.00539	CcSEcCtD
Prasugrel—Thrombocytopenia—Dactinomycin—sarcoma	0.00104	0.00538	CcSEcCtD
Prasugrel—Skin disorder—Thiotepa—sarcoma	0.00104	0.00538	CcSEcCtD
Prasugrel—Leukopenia—Mitoxantrone—sarcoma	0.00101	0.00525	CcSEcCtD
Prasugrel—Eye disorder—Etoposide—sarcoma	0.00101	0.00523	CcSEcCtD
Prasugrel—Ecchymosis—Doxorubicin—sarcoma	0.00101	0.00523	CcSEcCtD
Prasugrel—Neoplasm—Doxorubicin—sarcoma	0.00101	0.00523	CcSEcCtD
Prasugrel—Hypertension—Vincristine—sarcoma	0.001	0.0052	CcSEcCtD
Prasugrel—Cough—Mitoxantrone—sarcoma	0.000988	0.00511	CcSEcCtD
Prasugrel—CYP2B6—hematopoietic system—sarcoma	0.000982	0.0203	CbGeAlD
Prasugrel—Angiopathy—Etoposide—sarcoma	0.000981	0.00508	CcSEcCtD
Prasugrel—Hypertension—Mitoxantrone—sarcoma	0.000977	0.00506	CcSEcCtD
Prasugrel—Immune system disorder—Etoposide—sarcoma	0.000977	0.00506	CcSEcCtD
Prasugrel—Mediastinal disorder—Etoposide—sarcoma	0.000975	0.00505	CcSEcCtD
Prasugrel—CYP2C9—hematopoietic system—sarcoma	0.000972	0.0201	CbGeAlD
Prasugrel—Anaphylactic shock—Vincristine—sarcoma	0.000948	0.00491	CcSEcCtD
Prasugrel—Thrombocytopenia—Vincristine—sarcoma	0.000929	0.00481	CcSEcCtD
Prasugrel—Anaphylactic shock—Mitoxantrone—sarcoma	0.000924	0.00478	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Thiotepa—sarcoma	0.000923	0.00478	CcSEcCtD
Prasugrel—Fatigue—Thiotepa—sarcoma	0.000922	0.00478	CcSEcCtD
Prasugrel—Fatigue—Dactinomycin—sarcoma	0.000915	0.00474	CcSEcCtD
Prasugrel—Back pain—Etoposide—sarcoma	0.000911	0.00472	CcSEcCtD
Prasugrel—Thrombocytopenia—Mitoxantrone—sarcoma	0.000904	0.00468	CcSEcCtD
Prasugrel—Skin disorder—Mitoxantrone—sarcoma	0.000897	0.00465	CcSEcCtD
Prasugrel—Cerebrovascular accident—Epirubicin—sarcoma	0.000894	0.00463	CcSEcCtD
Prasugrel—Hypotension—Vincristine—sarcoma	0.000886	0.00459	CcSEcCtD
Prasugrel—Pain in extremity—Epirubicin—sarcoma	0.000876	0.00454	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000876	0.00454	CcSEcCtD
Prasugrel—Anaemia—Etoposide—sarcoma	0.00087	0.00451	CcSEcCtD
Prasugrel—Hypotension—Mitoxantrone—sarcoma	0.000863	0.00447	CcSEcCtD
Prasugrel—CYP2B6—skin of body—sarcoma	0.000854	0.0176	CbGeAlD
Prasugrel—ALB—testis—sarcoma	0.000854	0.0176	CbGeAlD
Prasugrel—Body temperature increased—Thiotepa—sarcoma	0.000846	0.00438	CcSEcCtD
Prasugrel—Leukopenia—Etoposide—sarcoma	0.000843	0.00436	CcSEcCtD
Prasugrel—Body temperature increased—Dactinomycin—sarcoma	0.000839	0.00435	CcSEcCtD
Prasugrel—Cerebrovascular accident—Doxorubicin—sarcoma	0.000827	0.00428	CcSEcCtD
Prasugrel—Dyspnoea—Mitoxantrone—sarcoma	0.000824	0.00426	CcSEcCtD
Prasugrel—Cough—Etoposide—sarcoma	0.000822	0.00425	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Vincristine—sarcoma	0.000819	0.00424	CcSEcCtD
Prasugrel—Fatigue—Vincristine—sarcoma	0.000818	0.00423	CcSEcCtD
Prasugrel—Hypertension—Etoposide—sarcoma	0.000813	0.00421	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000811	0.0042	CcSEcCtD
Prasugrel—Pain in extremity—Doxorubicin—sarcoma	0.000811	0.0042	CcSEcCtD
Prasugrel—ALB—liver—sarcoma	0.000807	0.0167	CbGeAlD
Prasugrel—Fatigue—Mitoxantrone—sarcoma	0.000796	0.00412	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000796	0.00412	CcSEcCtD
Prasugrel—Hypersensitivity—Thiotepa—sarcoma	0.000788	0.00408	CcSEcCtD
Prasugrel—Hypersensitivity—Dactinomycin—sarcoma	0.000782	0.00405	CcSEcCtD
Prasugrel—Anaphylactic shock—Etoposide—sarcoma	0.000768	0.00398	CcSEcCtD
Prasugrel—Asthenia—Thiotepa—sarcoma	0.000767	0.00397	CcSEcCtD
Prasugrel—Asthenia—Dactinomycin—sarcoma	0.000762	0.00394	CcSEcCtD
Prasugrel—Thrombocytopenia—Etoposide—sarcoma	0.000752	0.0039	CcSEcCtD
Prasugrel—Body temperature increased—Vincristine—sarcoma	0.00075	0.00388	CcSEcCtD
Prasugrel—Skin disorder—Etoposide—sarcoma	0.000746	0.00386	CcSEcCtD
Prasugrel—CYP3A4—hematopoietic system—sarcoma	0.000742	0.0153	CbGeAlD
Prasugrel—Diarrhoea—Thiotepa—sarcoma	0.000732	0.00379	CcSEcCtD
Prasugrel—Body temperature increased—Mitoxantrone—sarcoma	0.00073	0.00378	CcSEcCtD
Prasugrel—Diarrhoea—Dactinomycin—sarcoma	0.000726	0.00376	CcSEcCtD
Prasugrel—Hypotension—Etoposide—sarcoma	0.000718	0.00372	CcSEcCtD
Prasugrel—Dizziness—Thiotepa—sarcoma	0.000707	0.00366	CcSEcCtD
Prasugrel—Hypersensitivity—Vincristine—sarcoma	0.000699	0.00362	CcSEcCtD
Prasugrel—CYP2B6—lymphoid tissue—sarcoma	0.000691	0.0143	CbGeAlD
Prasugrel—Dyspnoea—Etoposide—sarcoma	0.000685	0.00355	CcSEcCtD
Prasugrel—Hypersensitivity—Mitoxantrone—sarcoma	0.000681	0.00352	CcSEcCtD
Prasugrel—Asthenia—Vincristine—sarcoma	0.000681	0.00352	CcSEcCtD
Prasugrel—Rash—Thiotepa—sarcoma	0.000674	0.00349	CcSEcCtD
Prasugrel—Dermatitis—Thiotepa—sarcoma	0.000674	0.00349	CcSEcCtD
Prasugrel—Headache—Thiotepa—sarcoma	0.00067	0.00347	CcSEcCtD
Prasugrel—Rash—Dactinomycin—sarcoma	0.000669	0.00347	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Etoposide—sarcoma	0.000663	0.00344	CcSEcCtD
Prasugrel—Asthenia—Mitoxantrone—sarcoma	0.000663	0.00343	CcSEcCtD
Prasugrel—Fatigue—Etoposide—sarcoma	0.000662	0.00343	CcSEcCtD
Prasugrel—CYP2C19—liver—sarcoma	0.00065	0.0134	CbGeAlD
Prasugrel—Diarrhoea—Vincristine—sarcoma	0.000649	0.00336	CcSEcCtD
Prasugrel—Haematuria—Epirubicin—sarcoma	0.000644	0.00333	CcSEcCtD
Prasugrel—Epistaxis—Epirubicin—sarcoma	0.000637	0.0033	CcSEcCtD
Prasugrel—Nausea—Thiotepa—sarcoma	0.000635	0.00329	CcSEcCtD
Prasugrel—Diarrhoea—Mitoxantrone—sarcoma	0.000632	0.00327	CcSEcCtD
Prasugrel—Nausea—Dactinomycin—sarcoma	0.000631	0.00327	CcSEcCtD
Prasugrel—Dizziness—Vincristine—sarcoma	0.000627	0.00325	CcSEcCtD
Prasugrel—ALB—lymph node—sarcoma	0.000619	0.0128	CbGeAlD
Prasugrel—Bradycardia—Epirubicin—sarcoma	0.000617	0.0032	CcSEcCtD
Prasugrel—Haemoglobin—Epirubicin—sarcoma	0.000609	0.00316	CcSEcCtD
Prasugrel—Body temperature increased—Etoposide—sarcoma	0.000607	0.00315	CcSEcCtD
Prasugrel—Haemorrhage—Epirubicin—sarcoma	0.000606	0.00314	CcSEcCtD
Prasugrel—Urinary tract disorder—Epirubicin—sarcoma	0.000599	0.0031	CcSEcCtD
Prasugrel—Rash—Vincristine—sarcoma	0.000598	0.0031	CcSEcCtD
Prasugrel—Dermatitis—Vincristine—sarcoma	0.000597	0.00309	CcSEcCtD
Prasugrel—Oedema peripheral—Epirubicin—sarcoma	0.000597	0.00309	CcSEcCtD
Prasugrel—Haematuria—Doxorubicin—sarcoma	0.000596	0.00309	CcSEcCtD
Prasugrel—Urethral disorder—Epirubicin—sarcoma	0.000594	0.00308	CcSEcCtD
Prasugrel—Headache—Vincristine—sarcoma	0.000594	0.00308	CcSEcCtD
Prasugrel—Epistaxis—Doxorubicin—sarcoma	0.000589	0.00305	CcSEcCtD
Prasugrel—Rash—Mitoxantrone—sarcoma	0.000582	0.00302	CcSEcCtD
Prasugrel—Dermatitis—Mitoxantrone—sarcoma	0.000582	0.00301	CcSEcCtD
Prasugrel—Headache—Mitoxantrone—sarcoma	0.000579	0.003	CcSEcCtD
Prasugrel—Bradycardia—Doxorubicin—sarcoma	0.000571	0.00296	CcSEcCtD
Prasugrel—Eye disorder—Epirubicin—sarcoma	0.000567	0.00293	CcSEcCtD
Prasugrel—Hypersensitivity—Etoposide—sarcoma	0.000566	0.00293	CcSEcCtD
Prasugrel—Haemoglobin—Doxorubicin—sarcoma	0.000564	0.00292	CcSEcCtD
Prasugrel—Nausea—Vincristine—sarcoma	0.000563	0.00292	CcSEcCtD
Prasugrel—Haemorrhage—Doxorubicin—sarcoma	0.000561	0.0029	CcSEcCtD
Prasugrel—Urinary tract disorder—Doxorubicin—sarcoma	0.000554	0.00287	CcSEcCtD
Prasugrel—Oedema peripheral—Doxorubicin—sarcoma	0.000553	0.00286	CcSEcCtD
Prasugrel—Asthenia—Etoposide—sarcoma	0.000551	0.00285	CcSEcCtD
Prasugrel—Angiopathy—Epirubicin—sarcoma	0.00055	0.00285	CcSEcCtD
Prasugrel—Urethral disorder—Doxorubicin—sarcoma	0.00055	0.00285	CcSEcCtD
Prasugrel—Nausea—Mitoxantrone—sarcoma	0.000549	0.00284	CcSEcCtD
Prasugrel—Immune system disorder—Epirubicin—sarcoma	0.000548	0.00284	CcSEcCtD
Prasugrel—Mediastinal disorder—Epirubicin—sarcoma	0.000546	0.00283	CcSEcCtD
Prasugrel—CYP2B6—testis—sarcoma	0.000538	0.0111	CbGeAlD
Prasugrel—Diarrhoea—Etoposide—sarcoma	0.000526	0.00272	CcSEcCtD
Prasugrel—Eye disorder—Doxorubicin—sarcoma	0.000524	0.00271	CcSEcCtD
Prasugrel—Back pain—Epirubicin—sarcoma	0.00051	0.00264	CcSEcCtD
Prasugrel—Angiopathy—Doxorubicin—sarcoma	0.000509	0.00264	CcSEcCtD
Prasugrel—CYP2B6—liver—sarcoma	0.000509	0.0105	CbGeAlD
Prasugrel—Dizziness—Etoposide—sarcoma	0.000508	0.00263	CcSEcCtD
Prasugrel—Immune system disorder—Doxorubicin—sarcoma	0.000507	0.00262	CcSEcCtD
Prasugrel—Mediastinal disorder—Doxorubicin—sarcoma	0.000506	0.00262	CcSEcCtD
Prasugrel—CYP2C9—liver—sarcoma	0.000504	0.0104	CbGeAlD
Prasugrel—Anaemia—Epirubicin—sarcoma	0.000488	0.00253	CcSEcCtD
Prasugrel—Rash—Etoposide—sarcoma	0.000484	0.00251	CcSEcCtD
Prasugrel—Dermatitis—Etoposide—sarcoma	0.000484	0.00251	CcSEcCtD
Prasugrel—Headache—Etoposide—sarcoma	0.000481	0.00249	CcSEcCtD
Prasugrel—Leukopenia—Epirubicin—sarcoma	0.000472	0.00245	CcSEcCtD
Prasugrel—Back pain—Doxorubicin—sarcoma	0.000472	0.00245	CcSEcCtD
Prasugrel—Cough—Epirubicin—sarcoma	0.00046	0.00238	CcSEcCtD
Prasugrel—Nausea—Etoposide—sarcoma	0.000456	0.00236	CcSEcCtD
Prasugrel—Hypertension—Epirubicin—sarcoma	0.000456	0.00236	CcSEcCtD
Prasugrel—Anaemia—Doxorubicin—sarcoma	0.000451	0.00234	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000446	0.00231	CcSEcCtD
Prasugrel—Leukopenia—Doxorubicin—sarcoma	0.000437	0.00226	CcSEcCtD
Prasugrel—Anaphylactic shock—Epirubicin—sarcoma	0.000431	0.00223	CcSEcCtD
Prasugrel—Cough—Doxorubicin—sarcoma	0.000426	0.00221	CcSEcCtD
Prasugrel—Thrombocytopenia—Epirubicin—sarcoma	0.000422	0.00218	CcSEcCtD
Prasugrel—Hypertension—Doxorubicin—sarcoma	0.000422	0.00218	CcSEcCtD
Prasugrel—Skin disorder—Epirubicin—sarcoma	0.000418	0.00217	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000413	0.00214	CcSEcCtD
Prasugrel—Hypotension—Epirubicin—sarcoma	0.000402	0.00208	CcSEcCtD
Prasugrel—Anaphylactic shock—Doxorubicin—sarcoma	0.000399	0.00206	CcSEcCtD
Prasugrel—Thrombocytopenia—Doxorubicin—sarcoma	0.00039	0.00202	CcSEcCtD
Prasugrel—Skin disorder—Doxorubicin—sarcoma	0.000387	0.002	CcSEcCtD
Prasugrel—CYP3A4—liver—sarcoma	0.000384	0.00794	CbGeAlD
Prasugrel—Dyspnoea—Epirubicin—sarcoma	0.000384	0.00199	CcSEcCtD
Prasugrel—Hypotension—Doxorubicin—sarcoma	0.000372	0.00193	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Epirubicin—sarcoma	0.000372	0.00193	CcSEcCtD
Prasugrel—Fatigue—Epirubicin—sarcoma	0.000371	0.00192	CcSEcCtD
Prasugrel—Dyspnoea—Doxorubicin—sarcoma	0.000355	0.00184	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000344	0.00178	CcSEcCtD
Prasugrel—Fatigue—Doxorubicin—sarcoma	0.000344	0.00178	CcSEcCtD
Prasugrel—Body temperature increased—Epirubicin—sarcoma	0.00034	0.00176	CcSEcCtD
Prasugrel—Hypersensitivity—Epirubicin—sarcoma	0.000317	0.00164	CcSEcCtD
Prasugrel—Body temperature increased—Doxorubicin—sarcoma	0.000315	0.00163	CcSEcCtD
Prasugrel—Asthenia—Epirubicin—sarcoma	0.000309	0.0016	CcSEcCtD
Prasugrel—Diarrhoea—Epirubicin—sarcoma	0.000295	0.00153	CcSEcCtD
Prasugrel—Hypersensitivity—Doxorubicin—sarcoma	0.000294	0.00152	CcSEcCtD
Prasugrel—Asthenia—Doxorubicin—sarcoma	0.000286	0.00148	CcSEcCtD
Prasugrel—Dizziness—Epirubicin—sarcoma	0.000285	0.00147	CcSEcCtD
Prasugrel—Diarrhoea—Doxorubicin—sarcoma	0.000273	0.00141	CcSEcCtD
Prasugrel—Rash—Epirubicin—sarcoma	0.000272	0.00141	CcSEcCtD
Prasugrel—Dermatitis—Epirubicin—sarcoma	0.000271	0.00141	CcSEcCtD
Prasugrel—Headache—Epirubicin—sarcoma	0.00027	0.0014	CcSEcCtD
Prasugrel—Dizziness—Doxorubicin—sarcoma	0.000264	0.00136	CcSEcCtD
Prasugrel—Nausea—Epirubicin—sarcoma	0.000256	0.00132	CcSEcCtD
Prasugrel—Rash—Doxorubicin—sarcoma	0.000251	0.0013	CcSEcCtD
Prasugrel—Dermatitis—Doxorubicin—sarcoma	0.000251	0.0013	CcSEcCtD
Prasugrel—Headache—Doxorubicin—sarcoma	0.00025	0.00129	CcSEcCtD
Prasugrel—Nausea—Doxorubicin—sarcoma	0.000237	0.00123	CcSEcCtD
